{"transactions":[{"id":710444,"issuer":{"id":137,"kind":"organization","name":"Laird Superfood, Inc.","symbol":"LSF"},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true}}],"security":"Option (right to buy)","published_at":"2026-07-13T23:55:09.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as to 25% of the shares on each of the first four anniversaries of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":9,"expiration_date":"2036-07-09","underlying":"Laird Superfood, Inc. Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-26-023470","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650696/000143774926023470/rdgdoc.xml","form_type":"4"}},{"id":710443,"issuer":{"id":137,"kind":"organization","name":"Laird Superfood, Inc.","symbol":"LSF"},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true}}],"security":"Option (right to buy)","published_at":"2026-07-13T23:55:09.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as to 25% of the shares on each of the first four anniversaries of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":6,"expiration_date":"2036-07-09","underlying":"Laird Superfood, Inc. Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001437749-26-023470","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650696/000143774926023470/rdgdoc.xml","form_type":"4"}},{"id":710442,"issuer":{"id":137,"kind":"organization","name":"Laird Superfood, Inc.","symbol":"LSF"},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true}}],"security":"Option (right to buy)","published_at":"2026-07-13T23:55:09.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as to 25% of the shares on each of the first four anniversaries of the grant date."}],"balance_after":60000,"derivative":{"exercise_price":4.36,"expiration_date":"2036-07-09","underlying":"Laird Superfood, Inc. Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001437749-26-023470","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650696/000143774926023470/rdgdoc.xml","form_type":"4"}},{"id":725286,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-26T21:57:25.000Z","date":"2026-06-24","kind":"grant","planned":false,"acquired":true,"shares":31746,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 24, 2027."}],"balance_after":31746,"derivative":{"exercise_price":3.45,"exercise_date":"2027-06-24","expiration_date":"2036-06-23","underlying":"Common Stock","underlying_shares":31746},"source":{"system":"sec-edgar","filing":"0001769529-26-000003","document":"wk-form4_1782511043.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000176952926000003/wk-form4_1782511043.xml","form_type":"4"}},{"id":865132,"issuer":{"id":6409,"kind":"organization","name":"Super League Enterprise, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T14:06:21.000Z","date":"2025-10-20","kind":"grant","planned":false,"acquired":true,"shares":1446,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents grant of RSUs. The RSUs will vest in full on the date of the Issuer's 2026 annual meeting of stockholders."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents grant of RSUs. The RSUs will vest in full on the date of the Issuer's 2026 annual meeting of stockholders."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 23, 2026, the Issuer effectuated a 1-for-12 reverse split (\"Reverse Split\") of the Issuer's common stock. This Form 5 reports holdings as of December 31, 2025, with all share amounts reported herein adjusted for the Reverse Split."}],"balance_after":2477,"source":{"system":"sec-edgar","filing":"0001769529-26-000002","document":"form5-03032026_020316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1621672/000176952926000002/form5-03032026_020316.xml","form_type":"5"}},{"id":865131,"issuer":{"id":6409,"kind":"organization","name":"Super League Enterprise, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-03T14:06:21.000Z","date":"2025-10-01","kind":"grant","planned":false,"acquired":true,"shares":962,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (\"RSUs\"). The RSUs vested in full on the date of the Issuer's annual meeting of stockholders held on October 20, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of restricted stock units (\"RSUs\"). The RSUs vested in full on the date of the Issuer's annual meeting of stockholders held on October 20, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On January 23, 2026, the Issuer effectuated a 1-for-12 reverse split (\"Reverse Split\") of the Issuer's common stock. This Form 5 reports holdings as of December 31, 2025, with all share amounts reported herein adjusted for the Reverse Split."}],"balance_after":1031,"source":{"system":"sec-edgar","filing":"0001769529-26-000002","document":"form5-03032026_020316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621672/000176952926000002/form5-03032026_020316.xml","form_type":"5"}},{"id":1100894,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-26T21:29:03.000Z","date":"2025-06-24","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 24, 2026."}],"balance_after":20000,"derivative":{"exercise_price":14.13,"exercise_date":"2026-06-24","expiration_date":"2035-06-23","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-25-033148","document":"wk-form4_1750973339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828025033148/wk-form4_1750973339.xml","form_type":"4"}},{"id":1423066,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-26T23:06:28.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":1.67,"exercise_date":"2024-06-15","expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-24-038470","document":"wk-form4_1724713582.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024038470/wk-form4_1724713582.xml","form_type":"4"}},{"id":1423065,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-26T23:06:28.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":17000,"derivative":{"exercise_price":1.64,"exercise_date":"2023-06-16","expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001628280-24-038470","document":"wk-form4_1724713582.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024038470/wk-form4_1724713582.xml","form_type":"4"}},{"id":1423064,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T23:06:28.000Z","date":"2024-08-23","kind":"sale","planned":false,"acquired":false,"shares":23000,"price":3.57,"value":82110.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The weighted average sale price for the transaction reported was $3.57, and the range of prices were between $3.52 and $3.64. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001628280-24-038470","document":"wk-form4_1724713582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024038470/wk-form4_1724713582.xml","form_type":"4"}},{"id":1423063,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T23:06:28.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":1.67,"value":33400.0,"ownership":{"direct":true},"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001628280-24-038470","document":"wk-form4_1724713582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024038470/wk-form4_1724713582.xml","form_type":"4"}},{"id":1423062,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-26T23:06:28.000Z","date":"2024-08-23","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":1.64,"value":4920.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001628280-24-038470","document":"wk-form4_1724713582.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024038470/wk-form4_1724713582.xml","form_type":"4"}},{"id":1470419,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-24T21:44:24.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 20, 2025."}],"balance_after":20000,"derivative":{"exercise_price":2.71,"exercise_date":"2025-06-20","expiration_date":"2034-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-24-029652","document":"wk-form4_1719265458.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828024029652/wk-form4_1719265458.xml","form_type":"4"}},{"id":1533599,"issuer":{"id":6409,"kind":"organization","name":"Super League Enterprise, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-29T23:16:40.000Z","date":"2023-09-07","kind":"grant","planned":false,"acquired":true,"shares":27027,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of restricted stock units (\"RSUs\") issued in connection with the Reporting Person's service on the Issuer's Board of Directors. The RSUs will vest in full on the date of the Issuer's 2024 annual shareholders meeting."}],"balance_after":32740,"source":{"system":"sec-edgar","filing":"0001415889-24-011710","document":"form4-04292024_110435.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621672/000141588924011710/form4-04292024_110435.xml","form_type":"4"}},{"id":1851612,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-16T21:26:43.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 15, 2024."}],"balance_after":20000,"derivative":{"exercise_price":1.67,"exercise_date":"2024-06-15","expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-23-022533","document":"wk-form4_1686950795.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828023022533/wk-form4_1686950795.xml","form_type":"4"}},{"id":2225044,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-21T22:23:32.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests 100% on June 16, 2023."}],"balance_after":20000,"derivative":{"exercise_price":1.64,"exercise_date":"2023-06-16","expiration_date":"2032-06-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001628280-22-017715","document":"wf-form4_165585019790330.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022017715/wf-form4_165585019790330.xml","form_type":"4"}},{"id":2224897,"issuer":{"id":6409,"kind":"organization","name":"Super League Enterprise, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-21T10:00:51.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":60000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (\"RSUs\") issued in connection with the Reporting Person's service on the Issuer's Board of Directors. The RSUs will vest in full on the date of the Issuer's 2023 annual shareholders meeting."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of restricted stock units (\"RSUs\") issued in connection with the Reporting Person's service on the Issuer's Board of Directors. The RSUs will vest in full on the date of the Issuer's 2023 annual shareholders meeting."}],"balance_after":114273,"source":{"system":"sec-edgar","filing":"0001415889-22-006795","document":"form4-06212022_060636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621672/000141588922006795/form4-06212022_060636.xml","form_type":"4"}},{"id":2294563,"issuer":{"id":6146,"kind":"organization","name":"Niagen Bioscience, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-04-20T00:27:47.000Z","date":"2022-04-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three substantially equal annual installments beginning on April 15, 2023."}],"balance_after":40000,"derivative":{"exercise_price":2.14,"exercise_date":"2023-04-15","expiration_date":"2032-04-14","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001628280-22-009591","document":"wf-form4_165041444722067.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1386570/000162828022009591/wf-form4_165041444722067.xml","form_type":"4"}},{"id":2685753,"issuer":{"id":6409,"kind":"organization","name":"Super League Enterprise, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-02T19:42:26.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":12474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of restricted stock units (\"RSUs\") issued in connection with the Reporting Person's service on the Issuer's Board of Directors. The RSUs will vest in full on the date of the Issuer's 2022 annual shareholders meeting."}],"balance_after":54273,"source":{"system":"sec-edgar","filing":"0001415889-21-002759","document":"form4-06022021_120609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621672/000141588921002759/form4-06022021_120609.xml","form_type":"4"}},{"id":3068981,"issuer":{"id":6409,"kind":"organization","name":"Super League Enterprise, Inc."},"owners":[{"id":30735,"kind":"person","name":"Patrick Kristin","position":1,"cik":"0001769529","reported_name":"Patrick Kristin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-04T14:48:48.000Z","date":"2020-08-03","kind":"grant","acquired":true,"shares":36344,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents grant of restricted stock units (\"RSUs\") issued in connection with the Reporting Person's service on the Issuer's Board of Directors. The RSUs will vest in full on the date of the Issuer's 2021 annual shareholders meeting."}],"balance_after":41799,"source":{"system":"sec-edgar","filing":"0001415889-20-002003","document":"form4-08042020_070822.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1621672/000141588920002003/form4-08042020_070822.xml","form_type":"4"}}]}